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Perofendic Acid, a Novel Substance
xtracted From Fetal Calf Serum, Protects Against
xidative Stress in Neonatal Rat Cardiac Myocytes
oshihiro Takeda, MD,* Masaharu Akao, MD, PHD,* Madoka Matsumoto-Ida, MD,* Masashi Kato, MD,*
iroyuki Takenaka, MD,* Yasuki Kihara, MD, PHD,* Toshiaki Kume, PHD,† Akinori Akaike, PHD,†
oru Kita, MD, PHD*
yoto, Japan
OBJECTIVES We examined whether serofendic acid (SFA) has protective effects against oxidative stress in
cardiac myocytes.
BACKGROUND We previously identified a novel endogenous substance, SFA, from a lipophilic extract of fetal
calf serum. Serofendic acid protects cultured neurons against the cytotoxicity of glutamate,
nitric oxide, and oxidative stress.
METHODS Primary cultures of neonatal rat cardiac myocytes were exposed to oxidative stress (H2O2, 100
mol/l) to induce cell death. Effects of SFA were evaluated with a number of markers of cell
death.
RESULTS Pretreatment with SFA (100 mol/l) significantly suppressed markers of cell death, as
assessed by terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling staining
and cell viability assay. Loss of mitochondrial membrane potential (m) is a critical step of
the death pathway, which is triggered by matrix calcium overload and reactive oxygen species.
Serofendic acid prevented the m loss induced by H2O2 in a concentration-dependent
manner (with saturation by 100 mol/l). Serofendic acid remarkably suppressed the
H2O2-induced matrix calcium overload and intracellular accumulation of reactive oxygen
species. The protective effect of SFA was comparable to that of a mitochondrial adenosine
triphosphate-sensitive potassium (mitoKATP) channel opener, diazoxide. Furthermore,
mitoKATP channel blocker, 5-hydroxydecanoate (500 mol/l), abolished the protective effect
of SFA. Co-application of SFA (100 mol/l) and diazoxide (100 mol/l) did not show an
additive effect. Thus, SFA inhibited the oxidant-induced mitochondrial death pathway,
presumably through activation of the mitoKATP channel.
CONCLUSIONS Serofendic acid protects cardiac myocytes against oxidant-induced cell death by preserving the
functional integrity of mitochondria. (J Am Coll Cardiol 2006;47:1882–90) © 2006 by the
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.12.055American College of Cardiology Foundation
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Aitochondria play critical roles in cell death in response to
variety of stresses, such as myocardial ischemia/reperfusion
1–3). Opening of the mitochondrial permeability transition
ore (MPTP), a non-specific pore that opens at the contact
ite between outer and inner mitochondrial membranes,
esults in the loss of mitochondrial membrane potential
m), matrix swelling, and the release of cytochrome c and
ther proapoptotic factors that lead to cell death (4–6).
itochondrial matrix calcium ([Ca2]m) overload and re-
ctive oxygen species (ROS) favor MPTP opening (7).
nhibition of MPTP opening by preventing [Ca2]m over-
oad and ROS generation will be an effective strategy for the
rotection of hearts from ischemia/reperfusion injury.
We have shown that adenosine triphosphate–sensitive
otassium channels located in the inner mitochondrial
embrane (mitoKATP channels) play a central role in the
ignaling cascade of protection against oxidative stress in the
ardiac ventricular myocytes (8,9) and the cerebellar granule
eurons (10,11). MitoKATP channels prevent [Ca
2]m
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Manuscript received June 19, 2005; revised manuscript received December 14,
005, accepted December 19, 2005.verload and ROS generation, thereby inhibiting the
PTP opening in both types of cells (10,12–14). Diazox-
de, a selective opener of mitoKATP channels, has been
hown to have protective effects against myocardial isch-
mia/reperfusion both in vitro (15,16) and in vivo (17,18).
nfortunately, the clinical use of this agent has been
ampered, owing to unwanted side effects, such as excessive
ypotension or edema.
We previously purified a novel neuroprotective substance
amed “serofendic acid” (SFA) derived from the lipophilic
raction of fetal calf serum (19). The compound exhibited
he ability to protect cultured cortical and striatal neurons
gainst glutamate, nitric oxide, and H2O2 cytotoxicity
19–22). Given that H2O2 is also responsible for the tissue
njury during myocardial ischemia/reperfusion, we hypoth-
sized that SFA might have cardioprotective effects against
schemia/reperfusion injury. In the present study, we inves-
igated whether SFA has protective effects against oxidative
tress in neonatal rat cardiac myocytes.
ETHODS
ll procedures were performed in accordance with the
yoto University animal experimentation committee, which
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nimals, published by the National Institutes of Health.
rimary culture of neonatal rat cardiac ventricular myo-
ytes. Cardiac ventricular myocytes were prepared from one-
o two-day-old Wistar rats and cultured as previously described
8). In brief, the hearts were removed, and the ventricles were
inced into small fragments, which were digested by trypsin
issociation. The dissociated cells were preplated for 1 h to
nrich the culture with myocytes. The non-adherent myocytes
approximately, 30 to 50 million cells per isolation) were then
lated in plating medium consisting of Dulbecco’s Modified
agle Medium (DMEM) (Nacalai Tesque, Kyoto, Japan)
upplemented with 5% fetal calf serum, penicillin (100
/ml), streptomycin (100 mg/ml), and 2 g/ml vitamin
12. The final myocyte cultures contained 90% cardiac
yocytes at partial confluence. The cells were maintained at
7°C in the presence of 5% CO2 in a humidified incubator.
romodeoxyuridine (0.1 mmol/l) was incubated in the
edium for the first three days after plating to inhibit
broblast growth. Cultures were then placed in serum-free
MEM containing vitamin B12 and transferrin 24 h before
he drug treatment.
xperimental protocol. Neonatal rat cardiac myocytes in
rimary culture were randomly assigned to one of three
xperimental groups: 1) control group; 2) incubation with
00 mol/l H2O2 for 60 min; and 3) pretreated 100 mol/l
FA for 30 min, followed by 100 mol/l H2O2 for 60 min.
t the beginning of the experiment, culture media were
eplaced with fresh serum-free DMEM containing those
rugs, and the cells were exposed to those drugs during the
ntire experimental period.
The SFA was dissolved in dimethyl sulfoxide to make
00 mmol/l stock solution before being added into experi-
ental solution. The final concentration of dimethyl sulf-
xide was 0.1%.
TS assay. Cell viability was quantified on the basis of
etabolic activity with the MTS assay (Promega, Madison,
Abbreviations and Acronyms
5-HD  5-hydroxydecanoate
m  mitochondrial membrane potential
[Ca2]m  mitochondrial matrix calcium
DAPI  4’,6-diamidino-2-phenylindole
DCF  chloromethyl-2,7-dichlorodihydrofluorescein
diacetate
DMEM  Dulbecco’s Modified Eagle Medium
FACS  fluorescence-activated cell sorter
MitoKATP  mitochondrial adenosine triphosphate-
sensitive potassium
MPTP  mitochondrial permeability transition pore
ROS  reactive oxygen species
SFA  serofendic acid
TMRE  tetramethylrhodamine ethyl ester
TUNEL  terminal deoxynucleotidyl transferase-
mediated dUTP nick end-labelingisconsin), according to manufacturer’s protocol. wThe cultures were incubated in serum-free medium
ontaining 20 l/well of the MTS tetrazolium compound
or 3 h at 37°C. The absorbance of formazan products was
hotometrically measured at 490 nm with a microplate
eader, ARVOsx (PerkinElmer, Shelton, Washington). The
ell viability was expressed as the percentage of the absor-
ance measured in the control group.
erminal deoxynucleotidyl transferase-mediated dUTP
ick end-labeling (TUNEL) staining. The TUNEL
taining was performed according to the manufacturer’s
rotocol (Roche, Indianapolis, Indiana). Fluorescein labels
ncorporated in nucleotide polymers were detected with a
uorescence microscope (Axioskop 2 plus; Zeiss, Thorn-
ood, New York).
=,6-diamidino-2-phenylindole (DAPI) staining. Cells
ere stained with the deoxyribonucleic acid binding dye
API (5 mol/l; Molecular Probes, Eugene, Oregon). The
uclear morphology of cells were visualized and photo-
raphed with the fluorescence microscope.
oading of cells with fluorescent indicator. To monitor
m, cells were loaded with tetramethylrhodamine ethyl
ster (TMRE) (Molecular Probes) 100 nmol/l at 37°C for
0 min. To monitor [Ca2]m, the cells were loaded with 2
mol/l rhod-2 AM (Molecular Probes) at 37°C for 30 min.
e assayed the intracellular ROS production with
hloromethyl-2,7-dichlorodihydrofluorescein diacetate
DCF) (Molecular Probes). Cells were loaded with 4
mol/l DCF at 37°C for 30 min, and the formation of the
xidized derivative was monitored by the increase of green
uorescence.
luorescence-activated cell sorter (FACS) analysis. Cells
lated on regular six-well plates (1.0 to 1.5 million cells per
ell) were used for the FACS analysis of m. The TMRE-
oaded cells were harvested by tripsinization at the end of the
xperimental protocols and analyzed with FACSAria (BD
iosciences, San Jose, California) (20,000 cells/sample). The
uorescence intensity of TMRE was monitored at 582 nm
FL-2). The FACS data were analyzed with analysis soft-
are (WinMDI).
onfocal imaging. Cells plated on 35-mm glass-bottom
ishes (1.0 to 1.5 million cells per dish) were maintained at
7°C in the presence of 5% CO2 with a heater platform
nstalled on a microscope stage and were placed in serum-
ree DMEM. After the desired temperature was reached,
ime-lapse confocal microscopy was started with 2-min
ntervals, with a 20 objective lens. Images were taken with
aser scanning confocal microscopy (LSM510, Zeiss). The
MRE and rhod-2 AM was excited with a 543 nm line of
helium/neon laser. The DCF was excited with a 488 nm
ine of an argon laser.
Twenty-five cells were randomly selected in each scan by
rawing regions around individual cells, and the red or
reen fluorescence intensity was sequentially monitored.
mage analysis. Quantitative image analysis was performed
ith an image analysis software (ImageJ).
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Serofendic Acid as a Novel Cardioprotective Agent May 2, 2006:1882–90tatistical analysis. All the quantitative data are presented
s the mean  SEM. Multiple comparisons among groups
ere carried out by one-way analysis of variance with
onferroni’s post-hoc test. A level of p 0.05 was accepted
s statistically significant.
ESULTS
igure 1A demonstrates TUNEL staining and DAPI stain-
ng in each experimental group. The TUNEL staining
etects nuclear deoxyribonucleic acid strand breaks, which
ccur during the terminal phase of apoptosis. Control cells
xhibited few TUNEL-positive nuclei, but exposure to 100
mol/l H2O2 for 16 h increased the number of TUNEL-
ositive nuclei, which can be seen as bright spots, indicating
nhanced apoptosis under the treatment with H2O2. There
ere obviously fewer TUNEL-positive nuclei in the SFA-
reated group, despite the similar density of cells compared
ith the H2O2 group. Cells incubated with 100 mol/l
2O2 for 16 h were also stained with deoxyribonucleic acid
inding dye DAPI. Fragmented or shrunken nuclei were
bserved in the H2O2 group, but SFA displayed a signifi-
ant protective effect in the preservation of nuclear mor-
hology. Figure 1B shows a quantitative determination of
UNEL-positive nuclei in each experimental group. The
ata indicate that SFA has a significant protective effect
gainst H2O2-induced nuclear damage.
We examined whether SFA would affect the overall
iability of cultured cardiac myocytes exposed to oxidative
tress. The MTS assay revealed that 100 mol/l SFA partly
ut significantly protected against H2O2-induced cytotox-
city (Fig. 1C).
Loss of m is a critical event early in the process of cell
eath and has been linked to the opening of MPTP (3–5).
o examine whether the preservation of m is associated
ith the cardioprotective effects of SFA, we assessed the
hange of TMRE fluorescence by H2O2 stimulation in each
roup with FACS analysis. The majority of cells in the
ontrol group (Fig. 2A, panel C) belonged to a population
ith a high TMRE fluorescence level (indicated by vertical
ashed line). Exposure to H2O2 shifted the predominant
opulation to a lower TMRE fluorescence (Fig. 2A, panel
). Serofendic acid protected against the H2O2-induced
oss of m, preserving a population of cells with a normal
m level (Fig. 2A, panel SFA). These observations were
endered quantitative by plotting the percentage of cells
ith high TMRE (300, in this case), as shown in Figure
B. Exposure to 100 mol/l H2O2 for 1 h resulted in
itochondrial depolarization, whereas SFA prevented the
oss of m in a concentration-dependent manner. The
m-preserving effect of SFA reached its maximum level at
00 mol/l. We further compared the protective effects of
FA with those of diazoxide, a mitoKATP channel opener.
n isolated cardiac myocytes, we previously reported that
iazoxide prevents the loss of m induced by oxidative
tress in a concentration-dependent manner (8). As shown 5n Figure 2C, the protective effect of 100 mol/l SFA was
omparable to 100 mol/l diazoxide (maximal protective
oncentration of diazoxide [8]) in preventing the loss of
m induced by 100 mol/l H2O2. The protection af-
orded by SFA and diazoxide was completely blocked by a
itoKATP channel blocker, 5-hydroxydecanoate (5-HD,
igure 1. (A) The terminal deoxynucleotidyl transferase-mediated dUTP
ick end-labeling (TUNEL) staining (left panels) and the nuclear coun-
erstaining by 4=,6-diamidino-2-phenylindole (DAPI) (right panels) in
eonatal rat cardiac myocytes. C  control cells; H  cells exposed to 100
mol/l H2O2 for 16 h; SFA  cells pretreated with 100 mol/l serofendic
cid for 30 min followed by 100 mol/l H2O2 for 16 h. Scale bars  20
m. (B) Quantitative determination of TUNEL-positive nuclei (n 
pproximately 3 to 4 for each group from two independent cultures). An
verage of 200 to 400 nuclei from random fields was analyzed in each
ample. (C) Cellular viability evaluated by MTS assay (n  13 for each
roup from two independent cultures). The H2O2 treatment was 3 h in this
xperiment. *p  0.05 versus group H.00 mol/l [8]). The 5-HD alone did not aggravate the loss
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May 2, 2006:1882–90 Serofendic Acid as a Novel Cardioprotective Agentf m elicited by 100 mol/l H2O2 (data not shown).
o-application of 100 mol/l diazoxide and 100 mol/l
FA did not exhibit an additive effect (Fig. 2C), because the
ombination of maximal protective concentrations of both
id not exceed each single drug. In addition, SFA alone in
he absence of H2O2 did not affect the control level of m
data not shown).
To further confirm the protective effect of SFA in
reventing the loss of m, we examined the time-
ependent changes of m on a single-cell basis (Fig. 3).
ime-lapse confocal analysis of cardiac myocytes loaded
ith TMRE was performed at 2-min intervals. Time-lapse
canning began immediately after the application of 50
mol/l H2O2. At first, we confirmed that TMRE fluores-
ence did not change during the 60 min of observation in
he control group (Fig. 3A, panels C). In contrast, cells
reated with H2O2 progressively lost their red fluorescence
ntensity, indicating the irreversible loss of m (Fig. 3A,
anels H). The TMRE fluorescence was remarkably pre-
erved in the SFA-treated group (Fig. 3A, panels SFA).
wenty-five cells were randomly selected in each group, and
he TMRE fluorescence intensity from each individual cell
as plotted in Figure 3B. Serofendic acid not only decreased
igure 2. Mitochondrial inner membrane potential (m) in neonatal rat
rom tetramethylrhodamine ethyl ester (TMRE)-loaded cells are shown. H
mol/l SFA for 30 min followed by 100 mol/l H2O2 for 1 h. In all of th
y a vertical dashed line. Results are representative data from at least thr
hat maintain high (300) TMRE fluorescence. Cells were pretreated wit
h. Serofendic acid preserved m in a concentration-dependent manne
MRE fluorescence. Cells were pretreated with various drugs for 30 min fol
iazoxide; 5-HD  500 mol/l 5-hydroxydecanoate. *p  0.05 versus H.
igure 1.he number of cells undergoing the dissipation of m but ilso delayed the onset of m loss, whereas it did not
hange the duration of m loss in unprotected cells.
igure 3C shows the average of TMRE fluorescence inten-
ity from 25 randomly selected cells in each group, indicat-
ng the significant protective effects of SFA.
Reactive oxygen species is one of the most important
nducers of MPTP opening. To investigate whether the
uppression of ROS production is associated with the
rotective effects of SFA, we assessed the change of DCF
uorescence by 50 mol/l H2O2 stimulation in each group
ith time-lapse confocal microscopy (Fig. 4). Cells in the
ontrol group gradually decreased the DCF fluorescence
ntensity (Fig. 4A, panels C). In the H2O2 group, the DCF
uorescence started to increase progressively upon H2O2
pplication (Fig. 4A, panels H). Serofendic acid suppressed
he increase in DCF fluorescence (Fig. 4A, panels SFA).
wenty-five cells were randomly selected from each group,
nd the DCF fluorescence intensity from each individual
ell was plotted in Figure 4B. The DCF fluorescence
ntensity of individual cells progressively increased in the
2O2 group, but the SFA-treated group blunted the overall
ncrease of DCF fluorescence compared with the H2O2
roup. Figure 4C shows the average of DCF fluorescence
c myocytes. (A) FL-2 histograms of fluorescence-activated cell sorter data
lls exposed to 100 mol/l H2O2 for 1 h; SFA  cells pretreated with 100
ograms, the position of the major population of control group is indicated
ependent experiments. (B) Representative data of the percentage of cells
ous concentrations of SFA for 30 min, followed by 100 mol/l H2O2 for
) Summarized data of the percentage of cells that maintain high (300)
by 100 mol/l H2O2 for 1 h. SFA 100 mol/l SFA; DZ 100 mol/l
0.05 versus corresponding 5-HD–absent group. Other abbreviations as incardia
 ce
e hist
ee ind
h vari
r. (C
lowedntensity from 25 randomly selected cells in each group.
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Serofendic Acid as a Novel Cardioprotective Agent May 2, 2006:1882–90Calcium overload in mitochondrial matrix is one of the
ritical triggers of cell death and is also an important inducer
f MPTP opening. To monitor the [Ca2]m level, we
erformed time-lapse confocal microscopy with the
Ca2]m sensitive dye, rhod-2, and observed the change of
uorescence due to 50 mol/l H2O2 stimulation in each
roup (Fig. 5). We first confirmed that the rhod-2 fluores-
ence did not change during 60 min of scanning in the
ontrol group (Fig. 5A, panels C). In the H2O2 group,
igure 3. Time-lapse analysis of m loss in neonatal rat cardiac myocyte
 cells exposed to 50 mol/l H2O2 for 1 h; SFA  cells pretreated wit
cale bars at 0 min frames: 20 m. (B) Time course of TMRE fluoresce
n three independent experiments. (C) Mean fluorescence intensity from 2
t the end of the experimental period. Other abbreviations as in Figure 1hod-2 fluorescence showed pronounced elevation at ap- groximately 20 min after H2O2 application, and the eleva-
ion persisted thereafter (Fig. 5A, panels H). Serofendic
cid also partly attenuated the [Ca2]m overload observed in
he H2O2 group (Fig. 5A, panels SFA). Figure 5B shows
he time course of the rhod-2 fluorescence intensity from
ach individual cell. Serofendic acid blunted the overall
ncrease of rhod-2 fluorescence compared with the H2O2
roup. Figure 5C shows the average of the rhod-2 fluores-
ence intensity from 25 randomly selected cells in each
) Representative sequential images of TMRE fluorescence in each group.
mol/l serofendic acid for 30 min followed by 50 mol/l H2O2 for 1 h.
f 25 cells randomly selected in each group. Similar results were obtained
ls randomly and prospectively selected in each group. *p  0.05 versus H
se see the Appendix for an accompanying video to this figure.s. (A
h 100
nce o
5 celroup.
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May 2, 2006:1882–90 Serofendic Acid as a Novel Cardioprotective AgentISCUSSION
FA as a cardioprotective agent. The major findings of
his study are as follows. First, in isolated cardiac myocytes,
FA suppressed the cell death induced by H2O2 by pre-
erving the m level in a concentration-dependent man-
er. The preservation of mitochondrial integrity was most
ikely achieved by the partial inhibition of [Ca2]moverload
nd ROS accumulation. Second, serofendic acid and
itoKATP opener exhibited comparable protective effects, and
igure 4. Time-lapse analysis of intracellular reactive oxygen species produ
hloromethyl-2,7-dichlorodihydrofluorescein diacetate (DCF) fluorescence
retreated with 100 mol/l serofendic acid for 30 min followed by 50 m
CF fluorescence of 25 cells randomly selected in each group. Similar re
ntensity from 25 cells randomly and prospectively selected in each group.
s in Figure 1. Please see the Appendix for an accompanying video to thihey did not have an additive beneficial effect on m Oreservation. MitoKATP channel blocker 5-HD canceled the
rotective effect of SFA. These observations suggest that
FA acts either directly on the mitoKATP channel or, rather,
pstream of the mitoKATP channel.
We previously reported the discovery of the neuroprotec-
ive compound SFA, extracted from fetal calf serum (19,20).
t is a low molecular weight substance of atisane-type
iterpenoids bearing a methylsulfoxide group, a unique
hemical structure among known endogenous substances.
in neonatal rat cardiac myocytes. (A) Representative sequential images of
ch group. H  cells exposed to 50 mol/l H2O2 for 30 min; SFA  cells
2O2 for 30 min. Scale bars at 0 min frames: 20 m. (B) Time course of
were obtained in three independent experiments. (C) Mean fluorescence
0.05 versus H at the end of the experimental period. Other abbreviations
re.ction
in ea
ol/l H
sults
*p ur unpublished data (T. Kume, A. Akaike, 2005) show
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Serofendic Acid as a Novel Cardioprotective Agent May 2, 2006:1882–90hat SFA is contained in fetal calf serum in a considerable
mount, but the content in adult bovine is below detectable
evel. Similarly, we were also unable to detect SFA in adult
uman serum, although there is a possibility that fetal
uman serum might contain SFA. The biosynthesis or the
etabolism of SFA is unknown at present. Previous studies
n vitro indicated that SFA has neuroprotective effects, as
videnced by the prevention of acute glutamate neurotoxic-
ty in cultured cortical neurons (21) and the attenuation of
igure 5. Time-lapse analysis of intracellular mitochondrial matrix calcium
Molecular Probes, Eugene, Oregon) fluorescence in each group. H  cell
erofendic acid for 30 min followed by 50 mol/l H2O2 for 1 h. Scale bar
andomly selected in each group. Similar results were obtained in three ind
nd prospectively selected in each group. *p  0.05 versus H at the end
ppendix for an accompanying video to this figure.OS-induced oxidative stress in cultured striatal neurons t22). Suppression of intracellular ROS generation might
onstitute an important mechanism of the neuroprotective
ctions of SFA, because the compound exhibits hydroxyl
adical-scavenging activity in electron spin resonance anal-
sis (19).
revention of MPTP by SFA. In recent studies, ROS
eneration and [Ca2]m overload have been proposed to
xplain the pathogenesis of ischemia/reperfusion injury of
he heart (3,23). Reactive oxygen species and [Ca2]m are
natal rat cardiac myocytes. (A) Representative sequential images of rhod-2
sed to 50 mol/l H2O2 for 1 h; SFA  cells pretreated with 100 mol/l
min frames: 20 m. (B) Time course of rhod-2 fluorescence of 25 cells
ent experiments. (C) Mean fluorescence intensity from 25 cells randomly
experimental period. Other abbreviations as in Figure 1. Please see thein neo
s expo
s at 0
epend
of thehe most important inducers of MPTP opening. A growing
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May 2, 2006:1882–90 Serofendic Acid as a Novel Cardioprotective Agentody of evidence supports the concept that the inhibition of
PTP is an effective and promising strategy to prevent
schemia/reperfusion injury of the heart (3,6,24,25). We
learly showed that SFA prevents MPTP opening, as
eported by the preservation of the cell population with
ully-polarized (intact) m levels. Notably, SFA only
artly suppressed the increases of [Ca2]m and ROS, but
his partial inhibition might decrease the number of cells
hat reach the threshold of the catastrophic loss of m.
his is consistent with the concept that mitochondria are
eath signal integrators and determine the fate of cells in an
ll-or-none manner (26).
We have recently shown that oxidant stress produces a
tereotyped progression of cellular changes in cardiac myo-
ytes (13). The first phase we call “priming”: mitochondria
ndergo [Ca2]m-dependent morphological changes, but
m remains unchanged. Next follows a sudden dissipation
f m mediated by the opening of MPTP (“depolariza-
ion” phase); eventually, cells break up into smaller frag-
ents (“fragmentation” phase). Serofendic acid markedly
ecreased the likelihood that cells would undergo priming:
Ca2]m overload was attenuated and, consequently, many
itochondria remained fully polarized. Serofendic acid not
nly decreased the number of cells undergoing m depo-
arization but also delayed the onset of m loss, whereas it
id not change the duration of depolarization in unpro-
ected cells. This mode of action is equivalent to that of the
itoKATP channel opener diazoxide (12), raising the pos-
ibility that the cytoprotective effects of SFA are directly or
ndirectly mediated by the mitoKATP channel. In the
resent study, we used two different concentrations of
2O2:50 mol/l in confocal time-lapse imaging, and 100
mol/l for all the other experiments, primarily because the
usceptibility of cells to H2O2 was dependent on the plating
urface. We have confirmed that cells underwent similar
hree-step progression of cell death in an all-or-none
anner, even when they were exposed to lower concentra-
ions of H2O2 (13).
FA and mitoKATP channel. It is clear that a cardiopro-
ective effect can be recruited by mitoKATP channel openers,
nd mitoKATP channel blockers (5-HD or glibenclamide)
revent both preconditioning and pharmacological cardio-
rotection (27–29). Furthermore, mitoKATP channel open-
ng prevents mitochondrial injury, presumably by inhibiting
he opening of MPTP (12,13). MitoKATP channel activa-
ion induces partial and modest m depolarization,
hereby reducing the driving force for calcium uptake by
itochondria and preventing [Ca2]m elevation (14). This
s further supported by the observation that partial m
epolarization elicited by the overexpression of uncoupling
rotein-2 also protected cardiac myocytes (30). In this
tudy, the protective effect of SFA was comparable to that of
iazoxide, and the co-application with SFA and diazoxide
id not show an additive effect. Furthermore, the mitoKATP
hannel blocker, 5-HD, abolished the protective effect of
FA. These results strongly suggest that the protectiveffect of SFA might be mediated by the activation of
itoKATP channels. Nevertheless, we could not rule out the
ossibility that SFA might act on the surface membrane
otential of cardiomyocytes and reduce cytosolic calcium
verload.
linical implications. Many pharmacological agents and
trategies have been administered for cardiac protection
uring acute myocardial infarction (31); however, none have
een translated into clinical practice (32). Therapeutic
nterventions designed to prevent MPTP opening during
schemia/reperfusion hold major promise as a novel strategy
or reducing cardiac injury from ischemia/reperfusion (6).
ur findings suggest SFA as a novel candidate for cardio-
rotective therapy against ischemia/reperfusion injury. Se-
ofendic acid is expected to be free from unpredictable side
ffects, because it is an endogenous substance. Despite the
ositive prospect of SFA as a novel cardioprotective agent,
urther investigations in animal models are needed to assess
he infarct size-limiting effect.
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